Ovid Therapeutics (OVID) - 2025 Q4 - Annual Results

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this "Agreement") is dated as of March 17, 2026, by and among Ovid Therapeutics Inc., a Delaware corporation (the "Company"), and each of the entities listed on Exhibit A attached to this Agreement (each, an "Investor" and together, the "Investors"). WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Secu ...